Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 8, 2001, Pages 973-975

  Grieco, Antonio ^a   Alfei, Barbara ^a   Di Rocco, Paola ^a   Miele, Luca ^a   Biolcati, Gianfranco ^a   Griso, Daniela ^a   Vecchio, Fabio Maria ^a   Bianco, Alessandro ^a   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Carbamazepine; Drug adverse reaction; Drug induced liver disease; Epilepsy; Keywords; Non alcoholic steatohepatitis; Porphyria; Toxic hepatitis; Variegate porphyria

Indexed keywords

CARBAMAZEPINE;

ADULT; ARTICLE; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EPILEPSY; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER TOXICITY; PORPHYRIA VARIEGATA; PRIORITY JOURNAL; TOXIC HEPATITIS; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; EPILEPSY; FATTY LIVER; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; PORPHYRIAS, HEPATIC; SKIN DISEASES;

EID: 0034890794     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200108000-00018     Document Type: Article

References (21)

1. Wolkenstein P, Tan C, Lecoeur S, Wechsler J, Garcia-Martin N, Charue D. et al. Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem Biol Intern 1998; 113: 39-50.
2. Cepelak I, Zanic Grubisic T, Mandusic A, Rekic B, Lenicek J. Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children. Clin Chim Acta 1998; 276: 121-127.
3. Martinez P, Gonzalez de Etxabarri S, Ereno C, Lopez G, Hinojal C, Teira R. Insufficiencia hepatica aguda grave por carbamacepina. Rev Esp Enf Digest 1993; 84: 124-126.
4. Forbes GM, Jeffrey GP, Shilkin KB, Reed WD. Carbamazepine hepatotoxicity: another cause of vanishing bile duct syndrome. Gastroenterology 1992; 102: 1385-1388.
5. Yeung Laiwah AC, Thompson GG, Philip MF, Brodie MJ, Rapeport WG, Moore MR. Carbamazepine-induced non-hereditary acute porphyria. Lancet 1983; i: 790-792.
6. D'Alessandro Gandolfo L, Topi GC. A new method for the determination of urinary porphyrins. Clin Chim Acta 1973; 49: 329-332.
7. Mauzeral D, Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956; 219: 435-436.
8. Grandchamp B, Phung G, Grelier M, Nordmann Y. The spectrophotometric determination of uroporphyrinogen I synthetase activity. Clin Chim Acta 1976; 70: 113-118.
9. De Verneuil H, Grandchamp B, Nordmann Y. Some kinetic properties of human red cell uroporphyrinogen decarboxylase. Biochem Biophys Acta 1980; 611: 174-186.
10. Kirsch RE, Meissner PN, Hift RJ. Variegate porphyria. Semin Liver Dis 1998; 18: 33-41.
11. Anderson KE. The porphyrias. In: Cecil Textbook of Medicine 21st ed. Goldman L, Bennat JC (editors): Philadelphia: Saunders Company; 2000. pp. 1123-1130.
12. Scarlett YV, Brenner DA. Porphyrias. J Clin Gastroenterol 1998; 27: 192-198.
13. Pasmans SGMA, Bruijnzeel-Koomen CAFM, van Reijsen FC. Skin reaction to carbamazepine. Allergy 1999; 54: 643-650.
14. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet 1999; 353: 2190-2194.
15. Rimington C, Lockwood WH, Belcher RV. The excretion of porphyrin-peptide conjugates in porphyria variegata. Clin Sci 1968; 38: 241-247.
16. Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia 1998; 39 (suppl 7): 3-7.
17. Campo E, Bruguera M, Rodes J. Are there diagnostic histologic features of porphyria cutanea tarda in liver biopsy specimens? Liver 1990; 10: 185-190.
18. Ishak K, Zimmerman HJ. Morphologic spectrum of drug-induced hepatic disease. Gastroenterol Clin North Am 1995; 24: 759-783.
19. Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221-229.
20. Lillibridge JH, Amore BM, Slattery JT, Kalhorn TF, Nelson SD, Finnell RH, Bennett GD. Protein-reactive metabolites of carbamazepine in mouse liver microsomes. Drug Metab Dispos 1996; 24: 509-514.
21. Sinclair PR, Gorman N, Tsyrlov IB, Fuhr U, Walton HS, Sinclair JF. Uroporphyrinogen oxidation catalyzed by human cytocromes P450. Drug Metab Dispos 1998; 26: 1019-1025.